SUMMARY The relationship between the histological diagnosis and serological and tissue markers of HBV replication in 41 Greek and 29 British patients with chronic HBV infection were studied. All the nine Greek and 13 British patients who were HBeAg positive had HBV-DNA in serum and HBcAg expression in the hepatocytes. The majority (73%) of these patients had active liver disease. Forty seven per cent of the Greek and 19% of the British patients who were anti-HBe positive continued to display HBcAg in the liver with or without HBV-DNA detected in serum. All but three of these patients had persistently active liver disease. Continuing inflammatory activity in the liver, however, was also found in 31% of anti-HBe positive patients who had no evidence of HBV replication. In these patients, other factors such as delta agent, NANB viruses, alcohol abuse or an autoimmune reaction initiated by HBV may be contributory.
There are two phases of chronic HBV infection. In the earlier phase, the patients are HBeAg positive. They have active viral replication as evidenced by the presence of HBV-DNA in serum1 2 and hepatitis B core antigen (HBcAg) in the liver.3 These patients usually have active disease because of continuous immunological attack on hepatocytes which bear viral antigens.i6 After a period of time, usually several years, viral replication ceases and the patients seroconvert from HBeAg to anti-HBe. 7 8 During this latter phase, the continuous production of HBsAg protein (22 nm Tables 1  and 2. FORTY ONE GREEK PATIENTS Nine were HBeAg positive, 30 were anti-HBe positive and the remaining two were negative for both HBeAg and anti-HBe.
All the nine patients who were HBeAg positive had evidence of active viral replication with HBV-DNA in serum and HBcAg in the liver. The majority (six), had chronic active hepatitis. The remaining patients had chronic persistent hepatitis (two) and active cirrhosis (one). Among the 30 anti-HBe positive patients (Table  3 ), 14 (47%) continued to display HBcAg in the hepatocytes, and eight of these also had HBV-DNA in the serum. Seventeen of these 30 patients (57%) had active liver disease: chronic active hepatitis (16) and active cirrhosis (one). In 11 there was evidence of persistent HBV replication. Intrahepatic HBcAg was also detected in one of these 11 patients. In the replication. In two of these, the liver biopsies had been taken within six months of HBeAg/anti-HBe seroconversion, and in the remaining patient there was coexistent delta infection. In the Greek patients serial specimens were not available so that the relationship of a particular serological pattern to HBe antigen/antibody seroconversion could not be determined. These patients were, however, similar to the British patients in that they had been referred to a hepatology service with symptomatic liver disease.
The explanation for the difference in the prevalence of low level HBV replication in the two populations of anti-HBe positive patients is not clear. Recent evidence suggests that clearance of hepatocytes supporting HBV replication is dependent on an immune response to HBc antigen3 21 whereas clearance of HBe antigen is related to an independent immune response to the determinants on this soluble protein. It is possible that both of these responses are independently genetically determined and in Greek patients the immune response to and the clearance of HBe antigen is more efficient than in British patients. Alternatively, the cell mediated response to HBc antigen displayed on the surface of hepatocytes supporting HBV replication may be less effective in Greek than British patients. The restricted number of epitopes displayed on HBe antigen -two identified by murine monoclonal antibodies22 -make it likely that very few immune response genes control the clearance of this antigen and therefore large differences may occur between different populations. Elimination of HBV infected hepatocytes probably depends on the recognition of viral antigens in association with HLA class 1 proteins by cytotoxic T lymphocytes. 23 It is possible that certain HLA types present in the Greek population may not associate as well as others with the HBV antigens leading to relative failure of immune lysis of infected hepatocytes.24 This has been reported in influenza.25 Thus, there are reasons to suggest that genetic factors may determine the difference between the Greek and British patients. Other factors may also be important. Unlike the British patients, most of the Greek patients were not studied serially and it remains possible that some of those who continued to replicate HBV during the anti-HBe phase, may have been biopsied near to seroconversion from HBeAg to anti-HBe, as was the case with the British patients. Finally, the time of infection may also determine the efficiency of the various components of the immune system. It is likely that the Greek patients are infected early in life, whereas the British patients acquire the infection in adulthood.
It has been suggested that inflammatory liver disease is associated with viral replication.4 Although the majority (68%) of HBeAg positive patients had active liver lesions on biopsy, 57% of Greek and 38% of British patients who were anti-HBe positive also had chronic active hepatitis or active cirrhosis. Fourteen of these 23 anti-HBe positive patients with active inflammatory liver disease also had persistent HBV replication showed by the presence of HBcAg in the liver or HBV-DNA in serum. The remaining nine patients, however, continued to have active liver disease in the absence of detectable HBV replication. Delta infection accounted for persistent inflammatory activity in only one of these patients. While 
